Latest stories

  • in

    NPPA Revises Ceiling Price of Dextrose Injection 25% w/v

    New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) of 12.1218%, through a recent a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of Dextrose Injection (25% w/v) in 100 ml […] More

  • in

    NPPA revises ceiling price of Coronary Stents

    New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, and the Government of India has revised the ceiling price of the two Coronary Stents, Bare Metal Stents and Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents. According to the new […] More

  • in

    NPPA revises ceiling price of Metronidazole Injection 0.5%w/v

    New Delhi:In accordance with price revision as per the annual wholesale price index (WPI) of 12.1218% increase, through a recent notification, the National Pharmaceuticals Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India, has revised and fixed the ceiling price of the metronidazole injection (0.5% w/v) under the Drug (Price Control) […] More

  • in

    NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroad

    NEET UG 2023: NTA revises eligibility criteria for Indian candidates abroad

    The NEET exam conducting body National Testing Agency (NTA) has revised the eligibility criteria for Indian candidates abroad seeking MBBS, BDS or AYUSH admissions in Indian institutes. Now, Indian candidates abroad including foreign nationals, Indian nationals, NRIs, Overseas Citizens of India (OCIs), and People of Indian Origin (PIOs) are all eligible for admission to MBBS, […] More

  • in

    NPPA Revises Ceiling Price Of 476 Scheduled Formulations, Details

    NPPA Revises Ceiling Price Of 476 Scheduled Formulations, Details

    New Delhi: In accordance with the price revision as per the annual wholesale price index increase of 12.1218%, through the recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of the 476 scheduled formulations under the Drug( Price Control) […] More

  • in

    Health Ministry revises CGHS Rates, Simplifies Referral Process, Details

    Health Ministry revises CGHS Rates, Simplifies Referral Process, Details

    New Delhi: In a move that is likely to be proved beneficial for both the patients and the hospitals, the Union Ministry of Health and Family Welfare has decided to revise the CGHS package rates for all CGHS beneficiaries and simplified the process of referral under CGHS for the benefit of its employees. The Union Health […] More

  • in

    NPPA Revises Ceiling Price of 233 Scheduled Formulation, Details

    New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) increase of 12.1218%, through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of 233 scheduled formulations under the Drug (Price Control) […] More

  • in

    NPPA fixes and revises ceiling price of 127 scheduled drugs, Details

    New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, the Government of India has fixed and revised the ceiling price of 127 scheduled formulations under the Drug (Price Control) Order, 2013. The list of 127 scheduled formulations includes Acetazolamide, Acetylsalicylic acid, Acyclovir, Albendazole, Amoxicillin, Amphotericin B, […] More